Zions Biocorporation (ZION) said late Thursday it priced $500 million of fixed-to-floating rate subordinated notes due Nov. 19, 2035.
Proceeds from the offering, which is expected to settle on Nov. 19, would help reduce short-term debt and redeem preferred shares and other securities.
The company said the interest rate that runs from, and includes, the settlement date to, but excludes Nov. 19, 2034, is equal to 6.816%, after which it switches to compounded SOFR plus 2.83%.
Price: 58.88, Change: -0.72, Percent Change: -1.21
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments